Hundreds of hospital and health system leaders today urged senators and representatives to support key priorities, including additional COVID-19 relief, during Congress’ lame-duck session.

During an advocacy event, AHA leaders discussed the need to urge Congress to:

  • provide COVID-19 relief, including additional money for the provider relief fund; federal liability protections; support for front-line health care workers; coverage for the uninsured; and full accelerated payment forgiveness for all hospitals;
  • eliminate cuts to the Medicaid disproportionate share hospital program in the next fiscal year; and
  • extend the congressionally enacted moratorium on the application of the Medicare sequester cuts until the public health emergency ends.

The AHA today also released two new resources – a fact sheet on why more federal support is needed to help hospitals and health systems weather the third COVID-19 wave and a fact sheet on how the pandemic has resulted in bankruptcies or closures for some hospitals.

AHA members today received an Action Alert, which includes more details and resources on the lame-duck priorities.

Related News Articles

Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…
Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…